Press Release

Sepsis Diagnostics Market 2019 Significant Growth Rate by Industry Size, Share, Market Dynamics, Development Status of Key Players Forecast to 2024

Sepsis

The “Sepsis Diagnostics Market” research report 2019-2024 delivers comprehensive information and valuable insights about the Sepsis Diagnostics industry. The information available in the Sepsis Diagnostics market report is not only based on the facts but also on the case studies, which analysts have included to convey appropriate information to the clients in a well-versed manner. Sepsis Diagnostics market report includes valuable information to assist new entrants, as well as established players, to understand the prevailing trends in the market.

Some Companies Are Covered in the Sepsis Diagnostics Market:

  • Abbott
  • Becton, Dickinson, and Company
  • bioMérieux SA
  • Bruker Corporation
  • F. Hoffmann
  • LA Roche Ltd
  • Immunexpress Inc.
  • Luminex Corporation
  • Response Biomedical Corp.
  • T2 Biosystems, Inc.
  • Thermo Fisher Scientific

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14099127

    Market Overview:

  • The major factors for the growth of the sepsis diagnostics market include the increasing prevalence of sepsis, the growing incidence of hospital-acquired infections, increasing number of pneumonia cases, rise in the number of sepsis procedures, and an increase in funding for sepsis-related research activities.
  • Hospital-acquired infections (HAIs) are the most common complications among hospitalized patients, with an estimated incidence of 4.5 HAIs per 100 hospital admissions and an annual cost ranging between USD 35 billion and USD 45 billion. These HAIs are also called nosocomial infection. According to the Centers for Disease Control and Prevention (CDC), about one in every 20 patients, who are admitted for the treatment, may develop a nosocomial infection. Hospital-acquired infections result in more than 99,000 deaths each year. HAIs are ranked among the top five leading causes of death in the United States. Some of the most common hospital-acquired infection cases include surgical infections, respiratory infections, urinary tract infections, and bloodstream infections. Post-surgery bloodstream infections have increased by 8%, while urinary tract infections, due to the use of a catheter after surgery, have increased by 3.6%, as per the American Hospital Association. Healthcare facilities, care teams, and individual doctors and nurses are also aware of infection-related issues and take specific steps to prevent them. Similar status of hospital-acquired infections has been observed across the world and is boosting the need for sepsis diagnosis. Hence, the rise in hospital-acquired infections is expected to drive the overall growth of the sepsis diagnosis market over the forecast period.

    Scope of the Report:

  • As per the scope of this report, sepsis diagnostics is the study of diagnosis of sepsis, which is a serious and life-threatening clinical condition that generally results from a primary bacterial infection or, less frequently, from a fungal and/or viral infection The market is segmented by technology, product, diagnostic method, pathogen, and geography.

    Reasons for Buying Sepsis Diagnostics Market Report:

    • This report provides pin-point analysis for changing competitive dynamics
    • It provides a forward looking perspective on different factors driving or restraining market growth
    • It provides a five-year forecast assessed on the basis of how the market is predicted to grow
    • It helps in understanding the key product segments and their future
    • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
    • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

    For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/14099127

    Key Market Trends:

    Molecular Diagnostics Segment under Technology-wise Segmentation is expected to be the Fastest Growing Segment over the Forecast Period.

    Sepsis, affecting nearly 1 out of every 23 hospitalized patients, is the sixth-most common reason for hospitalization. Rapid and accurate profiling of infection-causing pathogens remains a significant challenge in modern healthcare. Finally, identification of the causative pathogen is essential in selecting appropriate antibiotic therapy as part of the treatment. These requirements make molecular diagnostics (MDx) an attractive approach to consider for sepsis diagnostics. Molecular diagnostics have attracted several multinational companies and institutions, owing to their easy feasibility and accuracy in detection methods. The blood culture analysis for rapid and accurate profiling of infections has been the gold standard for the molecular diagnostic method. However, the cost of molecular diagnostics has remained very high, as compared to conventional procedures, which restricts its market growth. Several companies are investing in point of care molecular diagnostics for early diagnosis of bacterial and viral pathogens and better patient management. The well-established healthcare infrastructure with high adoption of advanced diagnostic technologies and raising awareness for early disease diagnosis is expected to drive the growth of the market studied.

    North America is expected to hold the Largest Market Share in the Global Market

    North America is found to hold a major share for the sepsis diagnostics market and is expected to show a similar trend over the forecast period, without significant fluctuations. According to the CDC statistics in 2018, sepsis affects more than a million Americans every year and leads to 15% to 30% deaths in the United States. Furthermore, the number of cases of sepsis is rising on a yearly basis in the country, due to factors, such as the rise in geriatric population, infections that are incurable by antibiotics, and higher risks of the disease among people who have undergone an organ transplant. The National Institutes of Health supports many studies that are focused on sepsis, which is evaluating various potential treatments for the disease. CDC launched the ‘Get Ahead of Sepsis’, which is an educational initiative to protect Americans from the effect of sepsis. This initiative calls on healthcare professionals to educate patients, prevent infections, identify and diagnose sepsis at an early stage, and start sepsis treatment fast. Emerging technologies linked with an enhanced understanding of the immature and developing neonatal immune system responses to early infection provide an opportunity to develop critically needed biomarkers to improve early identi?cation in this high-risk population. So, the increasing prevalence of sepsis, along with government initiative may augment the growth of the market studied.

    Sepsis Diagnostics Market Report Provides Comprehensive Analysis of:

    • Functional market industry outline
    • Up and downstream industry examination
    • Channels and propositions believability
    • Market challenge by key players
    • Enhancement suggestions examination

    Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/14099127

    Report Highlights:

    • Market Dynamics – Drivers, Restraints, and Opportunities
    • Market Segmentation – Types, Applications, Regions, and Technology
    • Market Trends
    • Competitive Landscape
    • SWOT Analysis and Porter’s Five Forces Analysis

    Detailed TOC of Sepsis Diagnostics Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Increasing Prevalence of Sepsis
    4.2.2 Growing Incidence of Hospital-acquired Infections
    4.2.3 Rise in the Number of Sepsis Procedures and Increase in Funding for Sepsis-related Research Activities
    4.3 Market Restraints
    4.3.1 High Cost of Automated Diagnostic Instruments
    4.3.2 Lack of Well-established Reimbursement Policies for Sepsis
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 By Technology
    5.1.1 Molecular Diagnostics
    5.1.2 Microbiology
    5.1.3 Immunoassay
    5.1.4 Other Technologies
    5.2 By Product
    5.2.1 Instruments
    5.2.2 Assays and Reagents
    5.2.3 Other Products
    5.3 By Diagnostic Method
    5.3.1 Conventional Diagnostics
    5.3.2 Automated Diagnostics
    5.4 By Pathogen
    5.4.1 Bacterial Sepsis
    5.4.2 Fungal Sepsis
    5.4.3 Other Pathogens
    5.5 Geography
    5.5.1 North America
    5.5.1.1 US
    5.5.1.2 Canada
    5.5.1.3 Mexico
    5.5.2 Europe
    5.5.2.1 Germany
    5.5.2.2 UK
    5.5.2.3 France
    5.5.2.4 Italy
    5.5.2.5 Spain
    5.5.2.6 Rest of Europe
    5.5.3 Asia-Pacific
    5.5.3.1 China
    5.5.3.2 Japan
    5.5.3.3 India
    5.5.3.4 Australia
    5.5.3.5 South Korea
    5.5.3.6 Rest of Asia-Pacific
    5.5.4 Middle East & Africa
    5.5.4.1 GCC
    5.5.4.2 South Africa
    5.5.4.3 Rest of Middle East & Africa
    5.5.5 South America
    5.5.5.1 Brazil
    5.5.5.2 Argentina
    5.5.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 Abbott
    6.1.2 Becton, Dickinson, and Company
    6.1.3 bioMérieux SA
    6.1.4 Bruker Corporation
    6.1.5 F. Hoffmann-LA Roche Ltd
    6.1.6 Immunexpress Inc.
    6.1.7 Luminex Corporation
    6.1.8 Response Biomedical Corp.
    6.1.9 T2 Biosystems, Inc.
    6.1.10 Thermo Fisher Scientific

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Automotive Automatic Transmission Market Size, share 2019 – Globally Industry Demand, Emerging Trends, Regional Overview, Top Manufacture, Top Company Analysis, Business Strategy and Forecast to 2024

    Global Composite Cylinders Market Size 2019 | Emerging Trends, Industry Share, Future Demands, Market Potential, Traders, Regional Overview and SWOT Analysis till 2024

    Infrared LED Market Growth by Manufacturers, Regions, Type and Application, Market Size, Forecast Analysis to 2025

    Memory Foam Pillow Market 2019 – Global Market Size, Analysis, Share, Research, Business Growth and Forecast to 2025 | Industry Research.co

    Tags
  • Alfredoo Epps

    Alfredo Epps is a finance expert heading the petroleum column. He joined the group last year as an associate writer. But his thorough research skills and ability to seamlessly putting numerical data into words helped him get a senior position. Apart from a column head, Alfredo is a dancer and a violinist.

    Related Articles

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    Close